You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myeloproliferative Disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Epidemiological and Clinical-pathological Factors of

Completed
  • Myeloproliferative Neoplasm
  • +4 more
    • Guayaquil, Guayas, Ecuador
      Sociedad de Lucha Contra el Cáncer
    Apr 25, 2023

    ph Negative Myeloproliferative Neoplasms: Impact on Outcome and

    Recruiting
    • Myeloproliferative Disease
    • Inflammatory Markers
      • Bari, Italy
      • +10 more
      Oct 21, 2022

      MDS, Acute Myeloid Leukemia With Myelodysplasia Related Disease and < 30% Blasts, Mixed Myelodysplastic/Myeloproliferative

      Recruiting
      • Myelodysplastic Syndromes
      • +2 more
      • Stockholm, Sweden
        Department of Hematology, Karolinska University Hospital
      Mar 27, 2023

      National Center for Precision Medicine in Leukemia

      Not yet recruiting
      • Acute Myeloid Leukemia
      • +4 more
      • Biobanking
      • (no location specified)
      Jun 7, 2022

      Myelodysplastic/Myeloproliferative Tumor, Steroid Refractory GVHD, Allogeneic Hematopoietic Cell Transplant Trial in Toronto

      Completed
      • Myelodysplastic/Myeloproliferative Neoplasm
      • +2 more
      • Decidual stromal cells (DSC)
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Jan 8, 2023

      Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myeloblasts 10 Percent or More of Bone Marrow Nucleated Cells Trial in

      Recruiting
      • Acute Myeloid Leukemia
      • +7 more
      • New Brunswick, New Jersey
        Rutgers Cancer Institute of New Jersey
      May 16, 2022

      Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

      Not yet recruiting
      • Acute Myeloid Leukemia
      • +5 more
      • Cytokine Induced Memory-like Natural Killer Cells
      • Interleukin-2
      • Boston, Massachusetts
      • +1 more
      Nov 14, 2023

      Hematologic Cancer Trial (experimental:Acute leukemia/myelodysplastic or myeloproliferative disease)

      Not yet recruiting
      • Hematologic Cancer
      • experimental:Acute leukemia/myelodysplastic or myeloproliferative disease
      • (no location specified)
      Oct 26, 2022

      Acute Myeloid Leukemia, MDS, Myeloproliferative Tumor Trial in Boston (CIML NK, Fludarabine, Cyclophosphamide)

      Recruiting
      • Acute Myeloid Leukemia
      • +3 more
      • CIML NK
      • +2 more
      • Boston, Massachusetts
      • +1 more
      Jan 6, 2023

      Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Buffalo (sargramostim)

      Completed
      • Chronic Myeloproliferative Disorders
      • +5 more
      • sargramostim
      • Buffalo, New York
        Roswell Park Cancer Institute
      Oct 3, 2022

      Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles

      Not yet recruiting
      • Clonal Cytopenia of Undetermined Significance
      • +4 more
      • Biospecimen Collection
      • +6 more
      • Los Angeles, California
      • +1 more
      Oct 4, 2023

      Pathogenesis of Hematologic Malignancies

      Enrolling by invitation
      • Acute Leukemia
      • +3 more
      • blood draw, bone marrow procedure, or tissue biopsy
      • Portland, Oregon
        OHSU Knight Cancer Institute
      Sep 9, 2022

      Multiple Myeloma, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Charlottesville (Pre-biotic foods/drinks)

      Completed
      • Multiple Myeloma
      • +11 more
      • Pre-biotic foods/drinks
      • Charlottesville, Virginia
        University of Virginia
      Jan 2, 2023

      Myeloproliferative Disorders, Lymphoproliferative Disorders Trial in Pierre-Bénite (Blood collection for the evaluation of the

      Not yet recruiting
      • Myeloproliferative Disorders
      • Lymphoproliferative Disorders
      • Blood collection for the evaluation of the anti-drugs sensitivity
      • Pierre-Bénite, France
      • +1 more
      Mar 2, 2022

      Leukemia, Acute Lymphoblastic, Myeloid Leukemia, Acute, Biphenotypic Acute Leukemia Trial in Saint Petersburg (Fludarabine,

      Recruiting
      • Leukemia, Acute Lymphoblastic
      • +5 more
      • Saint Petersburg, Russian Federation
        RM Gorbacheva Research Institute
      Jul 19, 2022

      Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit (3'-deoxy-3'-[18F]fluorothymidine)

      Recruiting
      • Brain and Central Nervous System Tumors
      • +8 more
      • 3'-deoxy-3'-[18F]fluorothymidine
      • Detroit, Michigan
        Barbara Ann Karmanos Cancer Institute
      Mar 30, 2022

      Myeloproliferative Neoplasia With Normal CBC and Thrombotic

      Recruiting
      • Thrombotic Patients
      • +2 more
        • Nantes, Loire-Atlantique, France
          Nantes University Hospital
        Sep 8, 2021

        Myeloid Leukemia, Acute, Chronic Myeloid Leukemia, MDS Trial in Saint Petersburg (Bendamustine Hydrochloride, Cyclophosphamid)

        Recruiting
        • Myeloid Leukemia, Acute
        • +3 more
        • Saint Petersburg, Russian Federation
          RM Gorbacheva Research Institute
        Apr 4, 2022

        Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Duarte (drug, procedure, other)

        Recruiting
        • Acute Lymphoblastic Leukemia
        • +6 more
        • Duarte, California
          City of Hope Medical Center
        Dec 8, 2022

        Tissue, Blood, and Body Fluid Sample Collection From Hematologic

        Recruiting
        • Chronic Myeloproliferative Disorders
        • +7 more
        • biologic sample preservation procedure
        • cytology specimen collection procedure
        • Chapel Hill, North Carolina
          Lineberger Comprehensive Cancer Center at University of North Ca
        Oct 14, 2021

        GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)

        Recruiting
        • GVHD
        • +15 more
        • Boston, Massachusetts
          Massachusetts General Hospital
        Sep 30, 2021

        Collecting and Storing Blood Samples From Patients With Cancer

        Withdrawn
        • Brain and Central Nervous System Tumors
        • +10 more
          • (no location specified)
          Sep 20, 2021

          Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Atlanta, Saint Louis, Columbus

          Active, not recruiting
          Has Results
          • Acute Myelogenous Leukemia
          • +10 more
          • Atlanta, Georgia
          • +2 more
          Feb 9, 2022

          Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute

          Active, not recruiting
          • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
          • +13 more
          • CMVpp65-A*0201 peptide vaccine
          • +2 more
          • Duarte, California
          • +4 more
          Jan 4, 2023

          Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial

          Active, not recruiting
          • Acute Leukemia
          • +14 more
          • Duarte, California
            City of Hope Medical Center
          Nov 18, 2022